{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:12:45Z","timestamp":1790921565598,"version":"4.1.0"},"reference-count":24,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE:<\/jats:title>\n                  <jats:p>Exposure to thimerosal, a mercury-containing preservative that is used in vaccines and immunoglobulin preparations, has been hypothesized to be associated with increased risk of autism spectrum disorder (ASD). This study was designed to examine relationships between prenatal and infant ethylmercury exposure from thimerosal-containing vaccines and\/or immunoglobulin preparations and ASD and 2 ASD subcategories: autistic disorder (AD) and ASD with regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>A case-control study was conducted in 3 managed care organizations (MCOs) of 256 children with ASD and 752 controls matched by birth year, gender, and MCO. ASD diagnoses were validated through standardized in-person evaluations. Exposure to thimerosal in vaccines and immunoglobulin preparations was determined from electronic immunization registries, medical charts, and parent interviews. Information on potential confounding factors was obtained from the interviews and medical charts. We used conditional logistic regression to assess associations between ASD, AD, and ASD with regression and exposure to ethylmercury during prenatal, birth-to-1 month, birth-to-7-month, and birth-to-20-month periods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>There were no findings of increased risk for any of the 3 ASD outcomes. The adjusted odds ratios (95% confidence intervals) for ASD associated with a 2-SD increase in ethylmercury exposure were 1.12 (0.83\u20131.51) for prenatal exposure, 0.88 (0.62\u20131.26) for exposure from birth to 1 month, 0.60 (0.36\u20130.99) for exposure from birth to 7 months, and 0.60 (0.32\u20130.97) for exposure from birth to 20 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>In our study of MCO members, prenatal and early-life exposure to ethylmercury from thimerosal-containing vaccines and immunoglobulin preparations was not related to increased risk of ASDs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2010-0309","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T03:58:08Z","timestamp":1284436688000},"page":"656-664","source":"Crossref","is-referenced-by-count":136,"title":["Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism"],"prefix":"10.1542","volume":"126","author":[{"given":"Cristofer S.","family":"Price","sequence":"first","affiliation":[{"name":"Abt Associates Inc, Cambridge, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Thompson","sequence":"additional","affiliation":[{"name":"National Center for Chronic Disease Prevention and Health Promotion,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Goodson","sequence":"additional","affiliation":[{"name":"Abt Associates Inc, Cambridge, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Croen","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia L.","family":"Hinrichsen","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Marcy","sequence":"additional","affiliation":[{"name":"Southern California Kaiser Permanente, and Center for Vaccine Research, University of California, Los Angeles, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Robertson","sequence":"additional","affiliation":[{"name":"Abt Associates Inc, Cambridge, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Eriksen","sequence":"additional","affiliation":[{"name":"Southern California Kaiser Permanente, and Center for Vaccine Research, University of California, Los Angeles, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Bernal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Kaiser Permanente ASD Center San Jose Northern California Region, Stanford University, Palo Alto, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shay","sequence":"additional","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Davis","sequence":"additional","affiliation":[{"name":"Center for Health Research Southeast, Kaiser Permanente, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"DeStefano","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2010,10,1]]},"reference":[{"issue":"5","key":"2021121010254133600_B1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1542\/peds.107.5.1147","article-title":"An assessment of thimerosal use in childhood vaccines","volume":"107","author":"Ball","year":"2001","journal-title":"Pediatrics"},{"key":"2021121010254133600_B2","volume-title":"Goldfrank's Toxicologic Emergencies","author":"Goldfrank","year":"2002","edition":"7th ed"},{"issue":"3 pt 1","key":"2021121010254133600_B3","first-page":"568","volume":"104","author":"Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS)","year":"1999","journal-title":"Pediatrics"},{"issue":"5","key":"2021121010254133600_B4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1542\/peds.112.5.1039","article-title":"Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases","volume":"112","author":"Verstraeten","year":"2003","journal-title":"Pediatrics"},{"issue":"13","key":"2021121010254133600_B5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMoa071434","article-title":"Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years","volume":"357","author":"Thompson","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"2021121010254133600_B6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.2008-0795","article-title":"Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines","volume":"123","author":"Tozzi","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"2021121010254133600_B7","first-page":"186","article-title":"The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA","volume":"78","author":"Chen","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"6","key":"2021121010254133600_B8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"issue":"5","key":"2021121010254133600_B9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.613","article-title":"The Vaccine Safety Datalink project","volume":"10","author":"DeStefano","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021121010254133600_B10","volume-title":"Thimerosal and Autism","author":"Price","year":"2009"},{"key":"2021121010254133600_B11","volume-title":"Thimerosal and Autism","author":"Price","year":"2009"},{"key":"2021121010254133600_B12","volume-title":"Autism Diagnostic Interview\u2014Revised","author":"Rutter","year":"2003"},{"key":"2021121010254133600_B13","volume-title":"Autism Diagnostic Observation Schedule","author":"Lord","year":"2003"},{"key":"2021121010254133600_B14","volume-title":"SCQ: The Social Communication Questionnaire","author":"Rutter","year":"2003"},{"key":"2021121010254133600_B15","volume-title":"Physicians' Desk Reference","year":"1995","edition":"49th ed"},{"issue":"3 pt 1","key":"2021121010254133600_B16","first-page":"570","article-title":"American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health","volume":"104","author":"Thimerosal in vaccines: an interim report to clinicians","year":"1999","journal-title":"Pediatrics"},{"key":"2021121010254133600_B17","volume-title":"Physicians' Desk Reference","year":"1999","edition":"53rd ed"},{"key":"2021121010254133600_B18","volume-title":"Logistic Regression: A Self-learning Text","author":"Kleinbaum","year":"2002"},{"key":"2021121010254133600_B19","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"2021121010254133600_B20","volume-title":"Immunization Safety Review: Vaccines and Autism","author":"Institute of Medicine","year":"2004"},{"issue":"1","key":"2021121010254133600_B21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2005-2993","article-title":"Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations","volume":"118","author":"Fombonne","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"2021121010254133600_B22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archgenpsychiatry.2007.1","article-title":"Continuing increases in autism reported to California's developmental services system: mercury in retrograde","volume":"65","author":"Schechter","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2021121010254133600_B23","doi-asserted-by":"crossref","first-page":"234.e1","DOI":"10.1016\/j.ajog.2008.04.044","article-title":"Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders","volume":"199","author":"Croen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"13","key":"2021121010254133600_B24","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/ajmg.a.31846","article-title":"Lack of association between Rh status, Rh immune globulin in pregnancy and autism","volume":"143A","author":"Miles","year":"2007","journal-title":"Am J Med Genet A"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/4\/656\/1058599\/zpe01010000656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/4\/656\/1058599\/zpe01010000656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T22:57:48Z","timestamp":1639177068000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/126\/4\/656\/65633\/Prenatal-and-Infant-Exposure-to-Thimerosal-From"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,10,1]]},"published-print":{"date-parts":[[2010,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-0309","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,1]]}}}